Search Results 171-180 of 21359 for anti-TNF drugs

1. Anti-Inhibitor Coagulant Complex (Intravenous Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

2. Mayo Clinic Q and A: Medications in use and being tested for treatment of COVID-19

   Researchers study many anti-inflammatory drugs to treat or prevent dysfunction of several organs and lung injury from infection-associated inflammation. Immune- ...

3. Valley fever - Symptoms & causes - Mayo Clinic

   People with certain autoimmune diseases, such as rheumatoid arthritis or Crohn's disease, who are being treated with anti-tumor necrosis factor (TNF) drugs also ...

4. Migraine medications and antidepressants: A risky mix? - Mayo Clinic

   Several medicines and medicine combinations may cause this to occur. SSRIs and SNRIs raise serotonin levels. Triptans interact directly with some serotonin ...

5. Atypical antidepressants - Mayo Clinic

   Nefazodone; Trazodone; Vilazodone (Viibryd); Vortioxetine (Trintellix). A new antidepressant called esketamine (Spravato) is FDA approved for treatment- ...

6. Fenoprofen (Oral Route) Description and Brand Names - Mayo Clinic

   Fenoprofen is a nonsteroidal anti-inflammatory drug (NSAID) used to treat mild to moderate pain, and helps to relieve symptoms of arthritis (osteoarthritis and ...

7. A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors - Mayo Clinic

   A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary ...

8. A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy - Mayo Clinic

   Subject who received any of the following agents: adalimumab, certolizumab, golimumab, infliximab, natalizumab, vedolizumab, within 8 weeks prior to Baseline; ...

9. A Phase 2 Study of Anti-PD-L1 Antibody Atezolizumab in Alveolar Soft Part Sarcoma - Mayo Clinic

   ... [anti-TNF] agents) within 2 weeks prior to cycle 1, day 1. Patients who have received acute, low dose, systemic immunosuppressant medications (e.g., a one ...

10. Medications and supplements that can raise your blood pressure - Mayo Clinic

    Pain medications · Indomethacin (Indocin). · Medicines available without a prescription such as aspirin (multiple doses a day), naproxen sodium (Aleve) and ...